Accell is the oncology-specialized full-service clinical CRO in Europe and CIS. We have been managing Phase I-III clinical trials for over a decade in 20+ countries. Backed by a strong operational strategy, a team of medical professionals, connections to prominent sites and assured relationships with oncology experts, Accell guarantees each clinical trial to be a success.
Currently, trials have a tendency to underperform in terms of patient recruitment. So, Accell became a true expert at rescuing studies. We have a record of steady metrics to guarantee each study to be completed on time.